Quintiles

Quintiles appoints Stella Blackburn to lead global risk management

Friday, March 28, 2014 12:33 PM

Quintiles has appointed Stella Blackburn, M.B. B.S., vice president and global head of Risk Management for its Real-World & Late Phase Research group. Blackburn will be responsible for leading the group’s risk management efforts in the U.S., E.U., Australia and Canada. Blackburn also will develop multidisciplinary risk management services, review and assist with interpretation of pharmacovigilance legislation and ensure compliance with regulations and best practices in the conduct of pharmacovigilance and risk management activities for the company’s real-world and late phase research efforts.

More... »

WIRB Copernicus Group

Quintiles launches secondary public offering of common stock

Monday, March 10, 2014 11:56 AM

Quintiles Transnational Holdings has launched a secondary public offering of its common stock by certain shareholders of Quintiles who are offering for sale to the public 15 million shares of Quintiles’ common stock owned by them.

More... »

CRF Health eCOA webinar series

Report: pharmacovigilance market, service providers to reach $5B globally in 2019

Friday, February 28, 2014 12:02 PM

According to a new market report published by Transparency Market Research, the global pharmacovigilance market was valued at $2,147.3 million in 2012 and is estimated to reach a market worth $5,008.2 million in 2019, at a CAGR of 12.9% from 2013 to 2019.

More... »

Quintiles receives Technology Security Award from IDG’s CSO Magazine

Wednesday, January 15, 2014 02:57 PM

Quintiles has been named to the 2014 CSO40 by IDG's CSO magazine for the second year in a row, recognizing its “Trusted Cloud Services Model” which extends internal security controls to cloud service providers. 

More... »

Quintiles, The Medical Affairs Company collaborate

Monday, January 13, 2014 11:40 AM

CROs Quintiles and The Medical Affairs Company (TMAC) have formed a new collaboration that will extend and enhance each company's existing medical affairs-related offerings for customers in the U.S.

More... »

Quintiles’ new mobile app gives patients safety information, pill reminders

Wednesday, January 8, 2014 01:30 PM

Information about potential adverse reactions from multiple medicines and a pill reminder that can be set for hourly, daily or weekly alerts are some of the features on a new mobile app created by Quintiles for users of its MediGuard service.

More... »

Vietnam Ministry of Health, Quintiles collaborate

Wednesday, November 20, 2013 12:46 PM

The Vietnam Ministry of Health’s Administration of Science, Technology and Training (ASTT) has signed a two-year agreement with Quintiles to enhance clinical research in Vietnam.

More... »

Quintiles launches Data-driven Trial Execution

Monday, November 18, 2013 01:33 PM

Quintiles has launched Data-driven Trial Execution, leveraging risk-based monitoring to improve clinical trial delivery.

More... »

Quintiles named a Best Multinational Workplace for third consecutive year

Thursday, October 31, 2013 09:00 AM

Quintiles has been recognized as one of the World’s Best Multinational Workplaces by Great Place to Work, ranking 18th on the 2013 list. 

More... »

Novella Clinical selected by Scioderm to manage rare disease study

Thursday, October 17, 2013 09:01 AM

CRO Novella Clinical, a Quintiles company, has been selected by Scioderm, is a privately held, clinical-stage pharmaceutical company, to manage a phase IIb trial for the treatment of Epidermolysis Bullosa (EB), a rare genetic connective tissue condition. The trial will evaluate Scioderm’s investigational topical product, SD-101, for the treatment of skin blistering and erosions associated with this disease, including facilitation of healing of skin lesions and reduction of the incidence and/or severity of new lesions.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 28

WCG acquires Alliance Biosciences to expand its biosafety oversight capabilities, ensure compliance

Facilitated review meetings for protocol design catching on, decreasing amendments, complexity

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs